Bioventus Inc. ( BVS) - Stock Earnings

BVS Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q3 3.2 million USD 138.7 million USD
2025Q4 14.8 million USD 157.9 million USD
2026Q1 3.1 million USD 132.1 million USD
2026Q2 Est.
2026Q3 Est.
2026Q4 Est.

BVS Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -156.2 million USD 512.3 million USD
2024 -33.5 million USD 573.3 million USD
2025 22.7 million USD 568.1 million USD
2026 Est.

BVS

Price: $8.51

52 week price:
5.81
11.25

Payout Ratio Range:
-157.39%
216.97%

Earnings Per Share: 0.41 USD

P/E Ratio: 24.85

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 617.9 million

Links: